Beckman Coulter Partners With South West London Pathology To Reduce the Impact of Sepsis In the UK
Beckman Coulter, a company specializing in clinical diagnostics, has announced that South West London Pathology (SWLP) has implemented DxH 900 hematology analyzers and the Early Sepsis Indicator across the SWLP network. SWLP is an award-winning NHS pathology partnership set up by St. George’s University Hospitals NHS Foundation Trust, Croydon Health Services NHS Trust and Kingston Hospital NHS Foundation Trust. The installation enables SWLP laboratories to provide a single, integrated pathology service to more than 3.5 million people across South West London via three hospitals, 200 GP practices and 30 community healthcare sites.
Beckman Coulter’s DxH 900 hematology analyzers are designed to enable clinical laboratories like SWLP to perform complete blood count and white blood cell differential tests. Demonstrating 93% first-pass yield, the DxH 900 aims to reduce the number of manual slide reviews, helping to generate reportable results as quickly as possible. In addition, the DxH 900 features the Early Sepsis Indicator, a CE marked and FDA-cleared hematologic biomarker that aids the diagnosis of sepsis in adult patients.